BullFrog AI Holdings (BFRG) Retained Earnings (2021 - 2026)
BullFrog AI Holdings' (BFRG) quarterly Retained Earnings came in at $33.2 million in Q2 2026, up 48.09% on a YoY basis from $22.4 million in Q2 2025, and up 30.74% quarter-over-quarter from $25.4 million in Q4 2025.
Analysis
BullFrog AI Holdings (BFRG) Retained Earnings (2021 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported Retained Earnings for 6 consecutive years, with $33.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Retained Earnings rose 48.09% year-over-year to $33.2 million; the trailing twelve-month figure through Jun 2026 stood at $33.2 million (up 48.09% YoY), and the FY2025 full-year result was $25.4 million, up 16.87% from the prior year.
- Retained Earnings climbed to $33.2 million in Q2 2026 per BFRG's latest filing, from $25.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $33.2 million in Q2 2026 and bottomed at -$4.4 million in Q4 2022.
- Historically, Retained Earnings has averaged $17.7 million across 5 years, with a median of $18.8 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings slumped 175.53% in 2022, then soared 380.68% in 2023.
- Over 5 years, Retained Earnings stood at -$4.4 million in 2022, then jumped by 380.68% to $12.3 million in 2023, then surged by 76.21% to $21.8 million in 2024, then gained by 16.87% to $25.4 million in 2025, then surged by 30.74% to $33.2 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $33.2 million, $25.4 million, and $23.8 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | -22.28 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 9.53 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 15.69 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 37.62 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 558.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 5.10 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 20.97 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 6.57 Bn |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 | 33.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.24 Mn |
| Dec 31, 2025 | 25.43 Mn |
| Sep 30, 2025 | 23.76 Mn |
| Jun 30, 2025 | 22.45 Mn |
| Mar 31, 2025 | 22.06 Mn |
| Dec 31, 2024 | 21.76 Mn |
| Sep 30, 2024 | 18.87 Mn |
| Jun 30, 2024 | 18.67 Mn |
| Mar 31, 2024 | 18.48 Mn |
| Dec 31, 2023 | 12.35 Mn |
| Sep 30, 2023 | 12.23 Mn |
| Jun 30, 2023 | 12.11 Mn |
| Mar 31, 2023 | 10.35 Mn |
| Dec 31, 2022 | -4.40 Mn |
| Dec 31, 2021 | -1.60 Mn |